Clinical implications of lamivudine resistance by HBV

Lancet

Volumn 349, Issue 9044, 1997, Pages 3-4

  Schalm, S W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; DNA POLYMERASE; LAMIVUDINE; VIRUS DNA;

CLINICAL TRIAL; DRUG RESISTANCE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER FAILURE; LIVER TRANSPLANTATION; NONHUMAN; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SHORT SURVEY; VIRUS REPLICATION;

EID: 0031033174     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)62154-X     Document Type: Note

References (7)

1. C Niederau T Heintges S Lange Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B N Engl J Med 333 1995 1657 1661
2. SW Schalm RA de Man RA Heytink Nieters HGM New nucleoside analogues for chronic hepatitis B J Hepatol 22 1995 52 56
3. JL Dienstag RP Perillo ER Schiff M Bartholomew C Vicary M Rubin A preliminary trial of lamivudine for chronic hepatitis B infection N Engl J Med 333 1995 1657 1661
4. Y Benhamou E Dohin F Lunel-Fabiani Effect of lamivudine on replication of hepatitis B virus in HIV-infected patients Lancet 345 1995 396 397
5. R Muller D Samuel LR Fassati JP Benhamou H Bismuth GJ Alexander ‘Eurohep’ consensus report on the management of liver transplantation for hepatitis B infection J Hepatol 21 1994 1140 1143
6. R Ling D Mutimer M Ahmed Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine Hepatology 24 1996 711 713
7. GA Tipples MM Ma KP Fischer VG Bain NM Kneteman DLJ Tyrrell Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo Hepatology 24 1996 714 717